The global atrial fibrillation surgery procedures market is expected to grow at a CAGR of 11.9% during the forecast period of 2015 to 2020. Over the past two decades, an increasing prevalence of atrial fibrillation cases is seen across the globe. According to American Heart Association, around 33.5 million people were suffering from atrial fibrillation around the world in 2013. Furthermore, about 200,000 to 400,000 new atrial fibrillation cases are diagnosed each year in the U.S.

This market is segmented on the basis of surgical procedures into catheter ablation and surgical ablation. Catheter and surgical ablation procedures are well accepted for the treatment of atrial fibrillation. Catheter ablation contributed to the maximum revenue in this market, in 2014. It will continue to hold dominant share in this market, growing at a CAGR of 14.5% during the forecast period of 2015 to 2020.

The geographical segmentation includes North America, Europe, Asia-Pacific and RoW. North America holds the largest share in this market, both in terms of the number of procedures and revenue. However, Asia-Pacific is expected to witness the highest growth rate due to the presence of a large patient population, increasing number of healthcare facilities, improving healthcare infrastructure, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India. Asia-Pacific atrial fibrillation catheter ablation market is expected to grow at a higher CAGR, compared to surgical ablation market, during the forecast period.

The key driver for this market is the increasing number of people suffering from atrial fibrillation. Favorable regulatory scenario would also propel growth in this market.

A combination of top-down and bottom-up approaches were used to calculate the market sizes and growth rates of the atrial fibrillation surgery market. Secondary information was used to identify the revenues, geographical reach and product portfolio of market players. Primary interviews were conducted with the key opinion leaders to validate the revenue estimates.

The report provides qualitative insights about the key market shares, growth rates and market dynamics. It also deals with company profiles of the market leaders. It includes financial performances, product portfolios and recent developments for each company. The report provides a competitive landscape which covers all the growth strategies adopted by market players and their share in atrial fibrillation market.

Reasons to Buy the Report:

The report would facilitate established as well as new entrants to determine the pulse of the market and help them formulate strategies.

The report provides insights on the following:

• Product Development: Product portfolios of the top players in atrial fibrillation market
• Competitive Assessment: In-depth analysis of market shares, strategies and product portfolios of leading market players
• Market Development: Extensive information about the lucrative emerging markets across geographies

Table of Content

1. Introduction
1.1. Objectives of the Study
1.2. Assumptions & Limitations

2. Research Methodology
2.1. Atrial Fibrillation Catheter and Surgical Procedures
2.2. Atrial Fibrillation Catheter and Surgical Ablation Market
2.3. Forecasting Model
2.4. Data Triangulation
2.5. Primary Respondent Profile

3. Atrial Fibrillation Catheter and Surgical Procedure
3.1. Overview
3.2. Catheter Ablation Procedures
3.3. Surgical Ablation/Maze Procedures

4. Atrial Fibrillation Surgery Product Market
4.1. Overview
4.2. Catheter Ablation Product Market
4.3. Surgical Ablation Market

5. Competitive Landscape
5.1. Market Share Analysis: Af Catheter Ablation Market, 2014
5.2. Market Share Analysis: Af Surgical Ablation Market, 2014
5.3. Competitive Landscape

6. Company Profiles (Business Overview, Company at Glance, Financials, Geographic Revenue Mix, Business Revenue Mix, Product Portfolio, Key Strategies, Recent Developments)
6.1. Biosense Webster, Inc.
6.2. Medtronic, Inc.
6.3. St. Jude Medical, Inc.
6.4. Boston Scientific Corporation
6.5. Atricure, Inc.
6.6. Cardiofocus, Inc.
6.7. Ncontact, Inc.
6.8. Carima, Inc.
6.9. Biotroik Se & Co.Kg

7. Appendix
7.1. Additional Insights
7.2. Secondary Resources
7.3. Related Reports

List of Tables

Table 1 Atrial Fibrillation Surgical Procedures, By Type of Procedure (Number of Procedures)
Table 2 Atrial Fibrillation Catheter Ablation Procedures, By Region (Number of Procedures)
Table 3 North America: Atrial Fibrillation Catheter Ablation Procedures, By Country (Number of Procedures)
Table 4 Europe: Atrial Fibrillation Catheter Ablation Procedures, By Country (Number of Procedures)
Table 5 Asia-Pacific: Atrial Fibrillation Catheter Ablation Procedures, By Country (Number of Procedures)
Table 6 Atrial Fibrillation Surgical Ablation/Maze Procedures, By Region (Number of Procedures)
Table 7 North America: Atrial Fibrillation Surgical Ablation/Maze Procedures, By Country (Number of Procedures)
Table 8 Europe: Atrial Fibrillation Surgical Ablation/Maze Procedures, By Country (Number of Procedures)
Table 9 Asia-Pacific: Atrial Fibrillation Surgical Ablation/Maze Procedures, By Country (Number of Procedures)
Table 10 Atrial Fibrillation Surgery Product Market, By Type of Procedure ($ Million)
Table 11 Global Atrial Fibrillation Catheter Ablation Product Market, By Region ($ Million)
Table 12 North America: Atrial Fibrillation Catheter Ablation Product Market, By Country ($ Million)
Table 13 Europe: Atrial Fibrillation Catheter Ablation Product Market, By Country ($ Million)
Table 14 Asia-Pacific: Atrial Fibrillation Catheter Ablation Product Market, By Country ($ Million)
Table 15 Atrial Fibrillation Surgical Ablation Product Market, By Region ($ Million)
Table 16 North America: Atrial Fibrillation Surgical Ablation Product Market, By Country ($ Million)
Table 17 Europe: Atrial Fibrillation Surgical Ablation Product Market, By Country ($ Million)
Table 18 Asia-Pacific: Atrial Fibrillation Surgical Ablation Product Market, By Country ($ Million)